Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Cerebrospinal fluid apolipoprotein E and phospholipid transfer protein activity are reduced in multiple sclerosis; relationships with the brain MRI and CSF lipid variables.
Neurodegeneration Triggers Peripheral Immune Cell Recruitment into the Forebrain.
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases.
Role of SIRT1 in autoimmune demyelination and neurodegeneration.
Potential For Cell-mediated Immune Responses In Mouse Models Of Pelizaeus-Merzbacher Disease.
Twenty years of experience on stem cell transplantation in iran.
An exploratory study on the spatial relationship between regional cortical volume changes and white matter integrity in Multiple Sclerosis.
Ocular nerve growth factor administration (oNGF) affects disease severity and inflammatory response in the brain of rats with experimental allergic encephalitis (EAE).
Muscular dystrophy in a patient with multiple sclerosis. Another "double-trouble"?
Thalamus pathology in multiple sclerosis: from biology to clinical application.
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management.
[Analysis of a series of cases with an initial diagnosis of acute disseminated encephalomyelitis over the period 2000-2010].
The cerebellar channelopathy of multiple sclerosis.
[Demyelinating diseases in children with acute neurological symptoms].
The relationship between executive functioning, processing speed, and white matter integrity in multiple sclerosis.
Cerebrospinal fluid oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald criteria 2010: Yes.
New data confirm high efficacy of Gilenya® in achieving 'no evidence of disease activity (NEDA)' based on four key measures of MS
Measuring myeloperoxidase activity in biological samples.
Isolated dysphagia due to aquaporin-4 autoimmunity.
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosis.
Interaction of mTOR and Erk1/2 signaling to regulate oligodendrocyte differentiation.
Successful treatment of neuromyelitis optica spectrum disorder by early initiation of plasma exchange.
Overview of the management of relapsing-remitting multiple sclerosis and practical recommendations.
Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.
Intrathecal Baclofen in Spinal Spasticity: Frequency and Severity of Withdrawal Syndrome.
Pages
« first
‹ previous
…
544
545
546
547
548
549
550
551
552
…
next ›
last »